Alkeon Capital Management LLC Avidity Biosciences, Inc. Transaction History

Alkeon Capital Management LLC

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2021 Feb 14, 2022	SELL	$20.4 - $28.66 $305,184 - $428,753	-14,960 Reduced 1.72%	856,466 $20.4 Million
Q2 2021 Aug 16, 2021	SELL	$19.62 - $29.26 $70,121 - $104,575	-3,574 Reduced 0.41%	871,426 $21.5 Million
Q3 2020 Nov 16, 2020	BUY	$23.35 - $35.94 $2.34 Million - $3.59 Million	100,000 Added 12.9%	875,000 $24.6 Million
Q2 2020 Aug 14, 2020	BUY	$26.62 - $31.5 $20.6 Million - $24.4 Million	775,000 New	775,000 $21.9 Million

252

107M

224K

161K

Ticker RNA
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 52,127,000
Market Cap $1.79B
Description
Avidity Biosciences, Inc., a biopharmaceutical company, engages in the development of oligonucleotide-based therapies. It develops antibody oligonucleotide conjugates (AOC) that are designed to treat a range of serious diseases. The company's lead product candidate AOC 1001 is used for the treatment of myotonic dystrophy type 1, a rare monogenic...

Get notified when there are updates to the investment portfolio of Alkeon Capital Management LLC, based on Form 13F filings with the SEC.

Stay updated on Alkeon Capital Management LLC with notifications on news.